ArticleArthritis research & therapy2018

A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance.

Raini Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.